Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
05-09 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
05-01 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
+13.14% | 4.84B | |
+7.66% | 1.61B | |
+43.38% | 1.27B | |
+23.31% | 911M | |
+82.85% | 881M | |
+20.63% | 626M | |
-28.34% | 534M | |
-.--% | 155M | |
+22.41% | 125M |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- Cullinan Oncology to Pay $25 Million for License Agreement With Harbour BioMed